Free Trial

Gyre Therapeutics (GYRE) SEC Filings & 10K Form

Gyre Therapeutics logo
$7.61 +0.12 (+1.60%)
Closing price 07/14/2025 04:00 PM Eastern
Extended Trading
$7.60 0.00 (-0.07%)
As of 07/14/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Gyre Therapeutics SEC Filings

DateFilerForm TypeView
06/05/2025
6:27 PM
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
5:13 PM
Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:46 PM
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
3:37 PM
Gyre Therapeutics (Filer)
Form 424B5
05/22/2025
4:27 PM
Gyre Therapeutics (Filer)
Form 424B5
05/14/2025
7:21 PM
Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:30 PM
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
6:05 AM
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
12:44 PM
Gyre Therapeutics (Filer)
Form ARS
04/21/2025
4:23 PM
Gyre Therapeutics (Filer)
Form DEF 14A
04/21/2025
4:23 PM
Gyre Therapeutics (Filer)
Form DEFA14A
03/20/2025
3:01 PM
Gyre Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/17/2025
3:15 PM
Gyre Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
7:00 PM
Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:02 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
5:01 AM
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
7:45 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:05 PM
Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:05 AM
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:06 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2024
11:15 PM
Gyre Therapeutics (Filer)
Form EFFECT
11/13/2024
3:05 PM
Gyre Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
7:45 PM
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
7:31 AM
Gyre Therapeutics (Subject)
Ma Songjiang (Filed by)
Form SC 13D
09/06/2024
7:15 AM
Gyre Therapeutics (Subject)
Luo Ying (Filed by)
Form SC 13D
08/16/2024
8:13 PM
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:53 PM
Chen Ruoyu (Reporting)
Gyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:56 PM
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:58 PM
Eastling Thomas Wilson (Reporting)
Gyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
8:01 PM
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
8:05 PM
Carmichael Gordon (Reporting)
Gyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
8:07 PM
Epstein David M. (Reporting)
Gyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
08/16/2024
8:10 PM
Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:50 PM
Gyre Therapeutics (Issuer)
Ying Han (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:04 PM
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:23 PM
Epstein David M. (Reporting)
Gyre Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
3:31 PM
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
3:27 PM
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
4:19 PM
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GYRE) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners